PharmaBoardroom

Pontus Billstam – Managing Director, Otsuka Pharma Nordics…

A relative newcomer to the Nordic countries, Otsuka has successfully built a strong foothold in the region. Pontus Billstam, managing director for the…

The Three Top Political Issues for Big Pharma

Eurasia Group’s Aditya Bhattacharji and Sarah Hassan identify and unpack the top three political and policy issues that multinational pharmaceutical…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Ukraine

The legal framework for cannabinoid drugs, medicinal cannabis and opioid drugs in Ukraine. Prepared in association with Sayenko Kharenko, a leading…

Regulatory Reforms: Ukraine

An insight into regulatory reforms in Ukrainian pharma. Prepared in association with Sayenko Kharenko, a leading law firm in Ukraine, this is an…

Amryt: A Rare Disease Startup Going Global

Formed in 2015, listed UK start-up Amryt targets rare diseases with high unmet medical need. With one commercial asset on the market, a strong…

Jay Hong – President, Kukjeon, South Korea

Kukjeon, originally a leading Korean pharmaceutical wholesaler, has in recent years expanded into API manufacturing. Its president, Jay Hong, explains…

The UK to Incentivise Big Pharma Firms to Develop New…

In recent years, apocalyptic conversations around superbugs caused by antimicrobial resistance (AMR) have been on the up, but just in case we were…

The 5 Most Influential Medical Research Charities in the UK

An unusual characteristic of the UK's healthcare landscape is that charities fund the vast majority of medical research. According to…

NHS England’s Long-Term Plan to be Funded by £20.5 Billion

Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK patients. The plan is…

GSK and Pfizer Consumer Health Divisions to Merge

The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint venture (JV) set to become the…

Steven Lynch – Managing Director, British Chamber of…

Steven Lynch, managing director of the British Chamber of Commerce in China, introduces the Chamber’s activities in support of their members, the…

Nationalism & Populism: A Roadblock for Global Pharma

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In his second piece for PharmaBoardroom, Aditya examines the dangers of…

Tagged with UK